Intec Pharma Ltd.

110 articles about Intec Pharma Ltd.

• Intec Pharma Granted Patent in Canada for Accordion Pill Carbidopa / Levodopa

  1/3/2018

  Intec Pharma today announced that the Canadian Intellectual Property Office has issued a Certificate of Grant of a Canadian patent No. 2,721,493.

• Intec Pharma Reports Third Quarter 2017 Operating and Financial Results

  11/16/2017

  Intec Pharma today announced its third quarter 2017 financial results and provided a corporate update.

• Intec Pharma Announces Changes to its Board of Directors

  11/1/2017

  Intec Pharma today announced that Mr. Zvi Joseph, founder and Mr. Giora Carni, former CEO of Intec Pharma, will step down from their roles as Directors on the Board of Intec Pharma, and plan to serve as advisors to the Company going forward.

• Intec Pharma Names Walt Linscott as Chief Administrative Officer

  10/26/2017

  Intec Pharma today announced it has named Mr. Walt Linscott to the position of Chief Administrative Officer.

• Intec Pharma Announces Closing Of $57.5 Million Public Offering Of Ordinary Shares

  8/22/2017

• Intec Pharma Announces Proposed Public Offering Of Ordinary Shares

  8/16/2017

• Intec Pharma Announces Pricing Of $50.0 Million Public Offering Of Ordinary Shares

  8/16/2017

• Intec Pharma Reports Financial Results For The First Six Months Of 2017

  8/10/2017

• Intec Pharma Reports Clinical Results From Phase I Trial Of Accordion Pill For Cannabinoid Therapies

  8/3/2017

• Intec Pharma Promotes Nadav Navon, Ph.D. To Chief Operating Officer

  7/26/2017

• Intec Pharma Granted Patent In Hong Kong For Accordion Pill Carbidopa / Levodopa

  7/19/2017

• Intec Pharma Appoints U.S. Life Sciences Executive And Vice Chairman Jeffrey A. Meckler As Chief Executive Officer

  7/10/2017

• Intec Pharma Granted U.S. Patent For Accordion Pill Comprising Levodopa For Improved Treatment Of Parkinson's Diseases Symptoms

  5/24/2017

• Intec Pharma CEO Resigns, Effecive Immediatly; Interim Leader Named

  5/3/2017

• Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler To Its Board Of Directors As Vice Chairman

  4/10/2017

• Intec Pharma Reports 2016 Fourth Quarter And Full Year Financial Results

  4/7/2017

• Intec Pharma Provides Update On Phase III ACCORDANCE Study Of The Accordion Pill Carbidopa/Levodopa In Parkinson's Disease Patients

  3/29/2017

• Intec Pharma Initiates Phase I Trial Of Accordion Pill For Cannabinoid Therapies

  3/22/2017

• Intec Pharma Announces $10 Million Private Placement

  3/10/2017

• Intec Pharma Enters Into Agreement With The Michael J. Fox Foundation Around Its Phase III Trial Recruitment

  11/28/2016